close

Enter

Log in using OpenID

Precision Medicine Market

embed
Global Precision Medicine Market Size 2017 by Application (Oncology, Central Nervous System, Cardiology, Infectious disease and Others), Region and Forecast 2018 to 2025
Adroit Market Research
Global Precision Medicine Market
Size 2017 by Application (Oncology, Central Nervous
System, Cardiology, Infectious disease and Others),
Region and Forecast 2019 to 2025
Single Use License: US$ 4850
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Request Sample
Adroit Market Research
Precision Medicine Market Size, Status and Forecast 2019-2025
• Adroit Market Research today published a study on the “Global Precision Medicine Market Size 2017 by Application
(Oncology, Central Nervous System, Cardiology, Infectious disease and Others), Region and Forecast 2018 to 2025”. The
global Precision Medicine market size is estimated based on the population genetic screening data, disease prevalence
rate and adoption of the precision medicines across the globe. Global Precision Medicine manufacturers have varying
products, depending on consumer genetic screening data. The report also provides various key strategies adopted by the
leading players as they mainly target prevalent diseases in the developed and developing economies. Precision Medicine
market share in various diseases has also been derived on the basis of thorough understanding of the forecast and
dynamics of various products under pipeline in various geographies. Also, the global Precision Medicine market size has
been laid down based on an extensive value chain analysis and patent analysis.
• The global precision medicine market size is projected to be valued USD 119.90 billion by 2025. Advancement in genomic
and proteomic sequencing with reduced costs, is bringing in the so-called “genomic revolution.” By identifying the optimal
point of intervention for treatment, healthcare providers massively improve the quality of care. Additionally, these
technologies offer optimized cost by effectively timing treatment intervention and eliminating the need for insufficient or
excessive treatment regimens.
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
Precision Medicine Market Size, Status and Forecast 2019-2025
• Next generation sequencing has shifted the paradigm of genomics by accomplishing entire genome sequencing in a matter
of hours. The enhanced speed and ease of DNA sequencing has drastically reduced the cost. The cost of deciphering the
entire human genome has dropped by an order of magnitude from USD 10,000 in 2011 to about USD 1,000 today. As
genome sequencing costs are declining rapidly healthcare providers and patients are likely to be more inclined to seek
treatments that are targeted to a particular illness.
• Cost is a major issue for precision medicines. Precision medicines may overburden many healthcare systems which are
currently under significant financial constraints. It is a major factor hindering the patient’s access to treatment. The new
targeted drugs that are launched in the market, are so highly priced that the patients can hardly afford them unless the cost
is fully covered by the payers.
Browse the complete report on @ https://www.adroitmarketresearch.com/industry-reports/precision-medicine-market
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
Precision Medicine Market Size, Status and Forecast 2019-2025
• Geographically, Asia Pacific led the precision medicine market share in the global market in 2017, growing with a CAGR of 14.38%
from 2018 to 2025. Globally, 40 countries have their individual versions of precision medicine ingenuities. United States and China
being one of them. China, is spending $43 for every $1 the United States is spending on its precision medicine initiatives. The
Beijing Genome Institute has the world's largest sequencer and repository of genetic material. Additionally, developments in
computational power and artificial intelligence are also in progress to discover new drugs, treatment and delivery methods. Wuxi
Nextcode and Huawei are collaboratively developing cloud computing infrastructure to store and compute enormous amounts of
data for precision medicines.
• Furthermore, the Korean government is strategizing framework for implementation of precision medicine into clinical practice. The
Korean Ministry of Food and Drug Safety, conducted a survey in 2012-2013, in order to explore the public awareness and attitude
towards precision medicine. Results of the survey demonstrated low levels of public awareness regarding precision medicine,
however, family income showed a positive correlation with precision medicine knowledge, thus reducing potential health disparities
will increase the access to precision medicine.
• Some of the leading players operating in the market include Novartis International AG, F. Hoffmann-La Roche AG, AstraZeneca plc,
Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Merck & Co. and others.
Purchase a single user copy of the global Precision Medicine Market [email protected]
https://www.adroitmarketresearch.com/researchreport/purchase/831
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
Precision Medicine Market Size, Status and Forecast 2019-2025
• Key segments of the global precision medicine market
• Application Overview, 2015-2025 (USD Million)
• Oncology
• CNS
• Cardiology
• Infectious disease
• Others
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
Precision Medicine Market Size, Status and Forecast 2019-2025
• Regional Overview, 2015-2025 (USD Million)
• North America
• U.S.
• Europe
• Germany
• UK
• France
• Asia-Pacific
• China
• Japan
• India
• Central & South America
• Brazil
• Middle East & Africa
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
About Us
Contact Us
Adroit Market Research is an India-based business analytics and consulting company. Our
target audience is a wide range of corporations, manufacturing companies, product/technology
development institutions and industry associations that require understanding of a market’s
size, key trends, participants and future outlook of an industry. We intend to become our
clients’ knowledge partner and provide them with valuable market insights to help create
opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At
our core, we are curious people who love to identify and understand industry patterns, create
an insightful study around our findings and churn out money-making roadmaps. Our analysts
have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals,
semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and
machinery & equipment sectors across the world to identify new opportunities, potential
customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for
companies, and many more.
US Headquarters
3131 McKinney Ave Ste 600 Dallas,
TX 75204 ,U.S.A
+1 (214) 884-6068
[email protected]
Phone: +1 (214) 884-6068
Email: [email protected]
www.adroitmarketresearch.com
Author
Simone singh
Simone singh45   documents Email
Document
Category
Health and Medicine
Views
1
File Size
69 KB
Tags
Precision Medicine Market, market
1/--pages
Report inappropriate content